
Kevin E. Weddington
Examiner (ID: 6966)
| Most Active Art Unit | 1614 |
| Art Unit(s) | 1614, 1205, 1629, 2899 |
| Total Applications | 3386 |
| Issued Applications | 2180 |
| Pending Applications | 434 |
| Abandoned Applications | 815 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4534265
[patent_doc_number] => 07872040
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-01-18
[patent_title] => 'Receptor blocker and vasodilator comprising indole derivative as active ingredient'
[patent_app_type] => utility
[patent_app_number] => 11/663748
[patent_app_country] => US
[patent_app_date] => 2005-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5950
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/872/07872040.pdf
[firstpage_image] =>[orig_patent_app_number] => 11663748
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/663748 | Receptor blocker and vasodilator comprising indole derivative as active ingredient | Sep 15, 2005 | Issued |
Array
(
[id] => 121876
[patent_doc_number] => 07709524
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-04
[patent_title] => 'Use of tellurium compounds for inhibition of interleukin-converting enzyme'
[patent_app_type] => utility
[patent_app_number] => 11/663032
[patent_app_country] => US
[patent_app_date] => 2005-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 10
[patent_no_of_words] => 15704
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/709/07709524.pdf
[firstpage_image] =>[orig_patent_app_number] => 11663032
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/663032 | Use of tellurium compounds for inhibition of interleukin-converting enzyme | Sep 14, 2005 | Issued |
Array
(
[id] => 5793096
[patent_doc_number] => 20060013777
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-19
[patent_title] => 'Novel treatment for cough'
[patent_app_type] => utility
[patent_app_number] => 11/225345
[patent_app_country] => US
[patent_app_date] => 2005-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9633
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0013/20060013777.pdf
[firstpage_image] =>[orig_patent_app_number] => 11225345
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/225345 | Novel treatment for cough | Sep 11, 2005 | Abandoned |
Array
(
[id] => 5814992
[patent_doc_number] => 20060084670
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-20
[patent_title] => 'Composition comprising camptothecin or a camptothecin derivative and a platin derivative for the treatment of cancer'
[patent_app_type] => utility
[patent_app_number] => 11/224658
[patent_app_country] => US
[patent_app_date] => 2005-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3128
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0084/20060084670.pdf
[firstpage_image] =>[orig_patent_app_number] => 11224658
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/224658 | Composition comprising camptothecin or a camptothecin derivative and a platin derivative for the treatment of cancer | Sep 11, 2005 | Abandoned |
Array
(
[id] => 4548899
[patent_doc_number] => 07960410
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-06-14
[patent_title] => 'Method for treating insulin resistance, abdominal obesity, hypertension, hyperinsulinemia, and elevated blood lipids with a cortisol inhibitor'
[patent_app_type] => utility
[patent_app_number] => 11/223074
[patent_app_country] => US
[patent_app_date] => 2005-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1507
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/960/07960410.pdf
[firstpage_image] =>[orig_patent_app_number] => 11223074
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/223074 | Method for treating insulin resistance, abdominal obesity, hypertension, hyperinsulinemia, and elevated blood lipids with a cortisol inhibitor | Sep 9, 2005 | Issued |
Array
(
[id] => 5794105
[patent_doc_number] => 20060014786
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-19
[patent_title] => 'Opthalmic pharmaceutical compositions and methods for treating ocular inflammation'
[patent_app_type] => utility
[patent_app_number] => 11/221744
[patent_app_country] => US
[patent_app_date] => 2005-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7037
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20060014786.pdf
[firstpage_image] =>[orig_patent_app_number] => 11221744
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/221744 | Opthalmic pharmaceutical compositions and methods for treating ocular inflammation | Sep 8, 2005 | Abandoned |
Array
(
[id] => 5199729
[patent_doc_number] => 20070299047
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-27
[patent_title] => 'Combination of Organic Compounds'
[patent_app_type] => utility
[patent_app_number] => 11/574994
[patent_app_country] => US
[patent_app_date] => 2005-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9600
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0299/20070299047.pdf
[firstpage_image] =>[orig_patent_app_number] => 11574994
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/574994 | Combination of Organic Compounds | Sep 7, 2005 | Abandoned |
Array
(
[id] => 5828852
[patent_doc_number] => 20060063702
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-23
[patent_title] => 'Neuromedin U 2 receptor agonists and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/222927
[patent_app_country] => US
[patent_app_date] => 2005-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 6886
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20060063702.pdf
[firstpage_image] =>[orig_patent_app_number] => 11222927
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/222927 | Neuromedin U 2 receptor agonists and uses thereof | Sep 7, 2005 | Abandoned |
Array
(
[id] => 5739123
[patent_doc_number] => 20060009514
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-12
[patent_title] => 'Method for treating obesity'
[patent_app_type] => utility
[patent_app_number] => 11/222135
[patent_app_country] => US
[patent_app_date] => 2005-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5417
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20060009514.pdf
[firstpage_image] =>[orig_patent_app_number] => 11222135
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/222135 | Method for treating obesity | Sep 6, 2005 | Abandoned |
Array
(
[id] => 5070385
[patent_doc_number] => 20070191487
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-16
[patent_title] => 'Galenic formulations of organic compounds'
[patent_app_type] => utility
[patent_app_number] => 11/219579
[patent_app_country] => US
[patent_app_date] => 2005-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9536
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20070191487.pdf
[firstpage_image] =>[orig_patent_app_number] => 11219579
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/219579 | Galenic formulations of organic compounds | Sep 1, 2005 | Abandoned |
Array
(
[id] => 5710091
[patent_doc_number] => 20060051436
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-09
[patent_title] => 'Composition for controlling excessive calorie intake-induced disorder, food product for controlling excessive calorie intake-induced disorder, skin preparation for external use for controlling excessive calorie intake-induced disorder, and controlling agent for excessive calorie intake-induced disorder'
[patent_app_type] => utility
[patent_app_number] => 11/219354
[patent_app_country] => US
[patent_app_date] => 2005-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 15995
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0051/20060051436.pdf
[firstpage_image] =>[orig_patent_app_number] => 11219354
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/219354 | Composition for controlling excessive calorie intake-induced disorder, food product for controlling excessive calorie intake-induced disorder, skin preparation for external use for controlling excessive calorie intake-induced disorder, and controlling agent for excessive calorie intake-induced disorder | Sep 1, 2005 | Abandoned |
Array
(
[id] => 5711108
[patent_doc_number] => 20060052453
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-09
[patent_title] => 'Agent for treating Parkinson\'s disease comprising astrocyte function-improving agent as active ingredient'
[patent_app_type] => utility
[patent_app_number] => 11/216114
[patent_app_country] => US
[patent_app_date] => 2005-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2471
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20060052453.pdf
[firstpage_image] =>[orig_patent_app_number] => 11216114
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/216114 | Agent for treating Parkinson's disease comprising astrocyte function-improving agent as active ingredient | Aug 31, 2005 | Abandoned |
Array
(
[id] => 5016718
[patent_doc_number] => 20070259927
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-08
[patent_title] => 'Remedy for Diabetes'
[patent_app_type] => utility
[patent_app_number] => 11/660939
[patent_app_country] => US
[patent_app_date] => 2005-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17612
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0259/20070259927.pdf
[firstpage_image] =>[orig_patent_app_number] => 11660939
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/660939 | Remedy for Diabetes | Aug 24, 2005 | Abandoned |
Array
(
[id] => 5777457
[patent_doc_number] => 20060106097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-18
[patent_title] => 'Metabolism-modulating agents and uses therefor'
[patent_app_type] => utility
[patent_app_number] => 11/205279
[patent_app_country] => US
[patent_app_date] => 2005-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 66194
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0106/20060106097.pdf
[firstpage_image] =>[orig_patent_app_number] => 11205279
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/205279 | Metabolism-modulating agents and uses therefor | Aug 15, 2005 | Issued |
Array
(
[id] => 5154935
[patent_doc_number] => 20070037818
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-15
[patent_title] => 'Discovery of valuable properties for the primary energy source \"PES 2000 plus Folic Acid\"'
[patent_app_type] => utility
[patent_app_number] => 11/203465
[patent_app_country] => US
[patent_app_date] => 2005-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 170
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20070037818.pdf
[firstpage_image] =>[orig_patent_app_number] => 11203465
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/203465 | Discovery of valuable properties for the primary energy source "PES 2000 plus Folic Acid" | Aug 14, 2005 | Pending |
Array
(
[id] => 5801376
[patent_doc_number] => 20060035864
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-16
[patent_title] => 'Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders'
[patent_app_type] => utility
[patent_app_number] => 11/202272
[patent_app_country] => US
[patent_app_date] => 2005-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7229
[patent_no_of_claims] => 123
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20060035864.pdf
[firstpage_image] =>[orig_patent_app_number] => 11202272
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/202272 | Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders | Aug 9, 2005 | Abandoned |
Array
(
[id] => 5711109
[patent_doc_number] => 20060052454
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-09
[patent_title] => 'Glycine as a diet supplement for the treatment of a wide range of health problems that result from underlying metabolic disorders'
[patent_app_type] => utility
[patent_app_number] => 11/199327
[patent_app_country] => US
[patent_app_date] => 2005-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11094
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20060052454.pdf
[firstpage_image] =>[orig_patent_app_number] => 11199327
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/199327 | Glycine as a diet supplement for the treatment of a wide range of health problems that result from underlying metabolic disorders | Aug 7, 2005 | Abandoned |
Array
(
[id] => 6978582
[patent_doc_number] => 20050288300
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-29
[patent_title] => 'Methods of use fluoroquinolone compounds against maxillary sinus pathogenic bacteria'
[patent_app_type] => utility
[patent_app_number] => 11/198040
[patent_app_country] => US
[patent_app_date] => 2005-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3674
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0288/20050288300.pdf
[firstpage_image] =>[orig_patent_app_number] => 11198040
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/198040 | Methods of use fluoroquinolone compounds against maxillary sinus pathogenic bacteria | Aug 7, 2005 | Abandoned |
Array
(
[id] => 7250046
[patent_doc_number] => 20050272641
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-08
[patent_title] => 'Therapeutic agents for diabetes'
[patent_app_type] => utility
[patent_app_number] => 11/198511
[patent_app_country] => US
[patent_app_date] => 2005-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10165
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0272/20050272641.pdf
[firstpage_image] =>[orig_patent_app_number] => 11198511
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/198511 | Therapeutic agents for diabetes | Aug 7, 2005 | Issued |
Array
(
[id] => 102498
[patent_doc_number] => 07728038
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-01
[patent_title] => 'Methods for chelation therapy'
[patent_app_type] => utility
[patent_app_number] => 11/197959
[patent_app_country] => US
[patent_app_date] => 2005-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 12
[patent_no_of_words] => 24508
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/728/07728038.pdf
[firstpage_image] =>[orig_patent_app_number] => 11197959
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/197959 | Methods for chelation therapy | Aug 3, 2005 | Issued |